INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2023

An umbrella review found berberine significantly affected blood glucose, insulin resistance, lipids, body parameters, and other health outcomes vs. controls.

An umbrella review searched PubMed, Cochrane Library, and Embase through June 30, 2022, to identify meta-analyses of RCTs assessing the efficacy and safety of berberine. Across 11 eligible meta-analyses, berberine significantly affected blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections compared to controls. Common side effects included gastrointestinal symptoms like constipation and diarrhea. The authors noted that methodological quality in published meta-analyses needs improvement and clinical effects need to be confirmed in high-quality RCTs.

Study type
Umbrella review of meta-analyses of RCTs
Who was studied
Participants across 11 eligible meta-analyses of RCTs
What was measured
Blood glucose, insulin resistance, blood lipids, body parameters/composition, inflammatory markers, colorectal adenomas, H. pylori, and adverse effects

THE PAPER

Berberine and health outcomes: An umbrella review.

Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, Tian Y, Wen Y, Chen T. Phytother Res, 2023.

PubMed 36999891 ↗DOI 10.1002/ptr.7806 ↗

Heart & arteriesDiabetes & blood sugarCancerGut & microbiomeWeight & appetiteOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.